Bristol-Myers Squibb Company
Carbazole derivatives
Last updated:
Abstract:
Disclosed are compounds of Formula (I): ##STR00001## or a salt thereof, wherein Q, R.sub.1a, R.sub.1b, R.sub.2a, R.sub.2b, R.sub.3, R.sub.4, R.sub.5a, R.sub.5b, R.sub.6a, R.sub.6c, R.sub.7a, R.sub.7b, R.sub.7c, and R.sub.7d are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
Status:
Grant
Type:
Utility
Filling date:
10 Apr 2019
Issue date:
9 Jun 2020